Showing results (121-130 of 146) with videos related to
Sort By:
Pageof 15
Vaccine|December 18, 2019
Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trialEd Clarke, Adedapo O Bashorun, Michael Okoye, et al.Human Vaccines & Immunotherapeutics|May 10, 2019
A phase 2/3 double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a seasonal trivalent inactivated split-virion influenza vaccine (IVACFLU-S) in healthy adults in VietnamPhan Trong Lan, Nguyen Trong Toan, Hoang Anh Thang, et al.NPJ Vaccines|November 25, 2025
One year follow up of phase 1/2 randomized, placebo controlled trial of NDV-HXP-S vaccine in ThailandWeerapong Phumratanaprapin, Viravarn Luvira, Saranath Lawpoolsri, et al.Journal of the Endocrine Society|December 28, 2020
PCSK-9 Inhibitors in a Real-World Setting and a Comparison Between Alirocumab and Evolocumab in Heterozygous FH PatientsJosé Juan Ceballos-Macías, Carolina Lara-Sánchez, Jorge Flores-Real, et al.Vaccine|December 9, 2019
A Phase 2/3 double blinded, randomized, placebo-controlled study in healthy adult participants in Vietnam to examine the safety and immunogenicity of an inactivated whole virion, alum adjuvanted, A(H5N1) influenza vaccine (IVACFLU-A/H5N1)Tran Nhu Duong, Vu Dinh Thiem, Dang Duc Anh, et al.Vaccine|August 11, 2025
Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S)Viravarn Luvira, Saranath Lawpoolsri, Weerapong Phumratanaprapin, et al.International Journal of Endocrinology|December 13, 2024
Efficacy of Local N-Acetylcysteine Administration in Mitigating OHSS Parameters: A Comparative Analysis With Dopaminergic Agonist in the OHSS ModelDulce Elena Letras-Luna, Nora Hilda Rosas-Murrieta, Nidia Gary Pazos-Salazar, et al.International Journal of Cardiology. Heart & Vasculature|June 1, 2022
Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain: <i>Win, Miranda</i> prediction of Chagas cardiomyopathySithu Win, Monica Miranda-Schaeubinger, Ronald Gustavo Durán Saucedo, et al.Vaccine|August 29, 2016
Randomized safety and immunogenicity trial of a seasonal trivalent inactivated split virion influenza vaccine (IVACFLU-S) in healthy young Vietnamese adultsDang Duc Anh, Vu Dinh Thiem, Nguyen Thi Hien Anh, et al.Plos Neglected Tropical Diseases|February 27, 2016
Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected PatientsYagahira E Castro-Sesquen, Robert H Gilman, Carolina Mejia, et al.Pageof 15